NeuroPace
Nasdaq NPCE · Mountain View, CA
Works in Genetic & rare · Neurology
NeuroPace is a clinical trial sponsor based in Mountain View, CA, listed as Nasdaq NPCE. It has 2 active clinical trials with 124 planned participants, in Genetic & rare and Neurology. Since 2021 it has completed 2 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq NPCE
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about NeuroPace
NeuroPace is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 124 planned participants, in Genetic & rare, Neurology. Since 2021 it has completed 2 trials and stopped 1 early.
NeuroPace is based in Mountain View, CA and is listed as Nasdaq NPCE. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with NeuroPace; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-16.
Approve Suite is not affiliated with NeuroPace.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.